| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/29/2003 | US6599698 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 07/29/2003 | US6599627 Microencapsulation of drugs by solvent exchange |
| 07/29/2003 | US6599540 Use of a Serenoa repens extract for the production of a medicament to treat prostate cancer |
| 07/29/2003 | US6599529 Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (NSAIDs) |
| 07/29/2003 | US6599527 Preparation of pharmaceutical compositions |
| 07/29/2003 | US6599519 Biodegradable poly(alkylene oxide)-poly(p-dioxanone) block copolymer soluble in organic solvents, and drug delivery composition comprising same |
| 07/29/2003 | US6599508 Truncated papillomavirus L1 protein, vaccine |
| 07/29/2003 | US6599507 Composition for the treatment of immune deficiencies and methods for its preparation and use |
| 07/29/2003 | US6599506 Inhibiting integrin-associated diseases; rejection of transplanted organs, allergies, and autoimmune diseases |
| 07/29/2003 | US6599501 Immunomodulators |
| 07/29/2003 | US6599495 Nucleotide and protein sequence of mammastatin and methods of use |
| 07/29/2003 | CA2288038C Polyethylene glycol-interferon alpha conjugates for therapy of infection |
| 07/29/2003 | CA2210444C Keratinocyte growth factor-2 |
| 07/29/2003 | CA2189971C Vaccine for moraxella catarrhalis |
| 07/29/2003 | CA2132982C Catalytic antibodies against cocaine and methods of using and producing same |
| 07/29/2003 | CA2131982C Tripeptide antithrombotic agents |
| 07/29/2003 | CA2117599C Method for modulating proopiomelanocortin synthesis in a mammal |
| 07/29/2003 | CA2094280C A method for transplanting cells into the brain and therapeutic uses therefor |
| 07/29/2003 | CA2093664C Modified ribozymes |
| 07/29/2003 | CA2078379C Method of treating immunoinflammatory disease |
| 07/29/2003 | CA2069481C Purified igc immunoglobulins |
| 07/29/2003 | CA2067136C Growth hormone antagonists |
| 07/29/2003 | CA2012125C Use of functional derivatives of the intercellular adhesion molecule icam-1 in anti-viral therapy |
| 07/29/2003 | CA1341435C Recombinant pox virus for immunization against tumor-associated antigens |
| 07/24/2003 | WO2003060525A1 Diagnostic and therapeutic use of the voltage-gated ion channel scn2a for neurodegenerative diseases |
| 07/24/2003 | WO2003060521A2 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 07/24/2003 | WO2003060468A2 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease |
| 07/24/2003 | WO2003060153A2 Irak-m is a negative regulator of toll-like receptor signaling |
| 07/24/2003 | WO2003060150A2 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling |
| 07/24/2003 | WO2003060149A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/24/2003 | WO2003060146A2 Compositions and methods relating to urinary specific genes and proteins |
| 07/24/2003 | WO2003060143A2 Efficient protein expression system |
| 07/24/2003 | WO2003060131A1 SUGAR TRANSFERASE GnT-V HAVING ANGIOGENIC EFFECT |
| 07/24/2003 | WO2003060130A2 Pim-3 kinase as a target for type 2 diabetes mellitus |
| 07/24/2003 | WO2003060126A1 Rheumatoid arthritis disease sensitive gene, its protein, method and kit of judging the onset of rheumatoid arthritis using the same, and method and drugs for treating rheumatoid arthritis |
| 07/24/2003 | WO2003060110A2 Regulation of human fatty acid coa ligase-like amp-binding enzyme |
| 07/24/2003 | WO2003060105A1 Defective entities and uses therefor |
| 07/24/2003 | WO2003060097A2 USE OF SOLUBLE Ϝδ T CELL RECEPTORS FOR REGULATING T CELL FUNCTION |
| 07/24/2003 | WO2003060096A2 Assay for the detection of factors that modulate the expression of ingap |
| 07/24/2003 | WO2003060091A2 Selective melanin-concentrating hormone type -1 receptor agonists |
| 07/24/2003 | WO2003060090A2 Novel cytokine zcytor17 ligand |
| 07/24/2003 | WO2003060089A2 Metalloproteins |
| 07/24/2003 | WO2003060085A2 Mammalian neural stem cells, compositions and uses thereof |
| 07/24/2003 | WO2003060082A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 07/24/2003 | WO2003060076A2 Povidone-containing carriers for polypeptide growth factors |
| 07/24/2003 | WO2003060075A2 USE OF SOLUBLE TYPE II TGF-β RECEPTOR TO SUPPRESS PANCREATIC CANCER GROWTH AND METASTASIS |
| 07/24/2003 | WO2003060072A2 Recombinant polypeptides |
| 07/24/2003 | WO2003060071A2 Albumin fusion proteins |
| 07/24/2003 | WO2003059987A1 Multidrop tree branching functional polyethylene glycol, the preparation method and the use of it |
| 07/24/2003 | WO2003059950A1 Ifnar2 mutants, their production and use |
| 07/24/2003 | WO2003059949A2 A protein that mediates angiogenesis and tumour growth inhibition, its cdna, alone or in complex with an expression vector |
| 07/24/2003 | WO2003059947A1 Regulation of human neurotransmitter transporter |
| 07/24/2003 | WO2003059946A2 Genetic polymorphisms predicting cardiovascular disease and medication efficacy |
| 07/24/2003 | WO2003059942A2 Peptides and peptidomimetics having anti-proliferative activity and their use |
| 07/24/2003 | WO2003059941A1 Biomolecule transduction motif mph-1-btm and the use thereof |
| 07/24/2003 | WO2003059940A1 Biomolecule transduction motif sim-2-btm and the use thereof |
| 07/24/2003 | WO2003059939A1 Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds |
| 07/24/2003 | WO2003059933A2 Conformationally constrained c-backbone cyclic peptides |
| 07/24/2003 | WO2003059932A2 Methods of inducing or enhancing connective tissue repair |
| 07/24/2003 | WO2003059927A1 Compositions and methods relating to endometrial specific genes and proteins |
| 07/24/2003 | WO2003059898A2 Eponemycin and epoxomicin analogs and uses thereof |
| 07/24/2003 | WO2003059886A1 Acyl sulfonamide derivative |
| 07/24/2003 | WO2003059881A2 Dna minor groove binding compounds |
| 07/24/2003 | WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/24/2003 | WO2003059873A1 Potassium channel modulators |
| 07/24/2003 | WO2003059871A1 N-alkylsulfonyl-substituted amide derivatives |
| 07/24/2003 | WO2003059436A2 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 07/24/2003 | WO2003059396A1 Adiponectin gene therapy |
| 07/24/2003 | WO2003059395A2 Antisense compounds directed against human csf-1 |
| 07/24/2003 | WO2003059389A1 Medicinal compositions for improving oral absorption |
| 07/24/2003 | WO2003059387A2 Combination comprising anti-cd52 antibodies and other therapeutic agents for treatment for multiple sclerosis |
| 07/24/2003 | WO2003059385A2 Hiv vaccine and method of use |
| 07/24/2003 | WO2003059378A2 Combined use of a glp-1 compound and another drug for treating dyslipidemia |
| 07/24/2003 | WO2003059377A1 Treatment for intracranial tumors |
| 07/24/2003 | WO2003059376A1 The use of il6r/il6 chimera in nerve cell regeneration |
| 07/24/2003 | WO2003059374A2 Use of dimer-specific nuclear localisation signal peptides (dsnls) derived from the stat dna binding domain |
| 07/24/2003 | WO2003059373A2 Compositions and their use for enhancing and inhibiting fertilization |
| 07/24/2003 | WO2003059372A2 Combined use of a glp-1 compound and a modulator of diabetic late complications |
| 07/24/2003 | WO2003059363A1 Methods and compositions for oxygen transport comprising a high oyzgen affinity |
| 07/24/2003 | WO2003059355A1 Quinazolinone compounds in combined modalities for improved cancer treatment |
| 07/24/2003 | WO2003059330A1 Stable pharmaceutical compositions comprising ace inhibitor(s) |
| 07/24/2003 | WO2003059329A2 Polytartrate composition |
| 07/24/2003 | WO2003059326A1 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties |
| 07/24/2003 | WO2003059296A2 Compositions comprising collagen and metalloprotease inhibitors |
| 07/24/2003 | WO2003059291A2 Treatment of bone disorders with skeletal anabolic drugs |
| 07/24/2003 | WO2003059290A2 Diagnostic and therapeutic uses of topors |
| 07/24/2003 | WO2003059287A2 Methods and compositions for oxygen transport comprising an oxygen carrier and a crystalloid in hypertonic solution |
| 07/24/2003 | WO2003059286A2 Methods and compositions for oxygen transport comprising modified hemoglobin in plasma |
| 07/24/2003 | WO2003059277A2 Methods and compositions for stimulating bone growth using inhibitors of microtubule assembly |
| 07/24/2003 | WO2003059276A2 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 07/24/2003 | WO2003059273A2 Antibody-avidin fusion proteins as cytotoxic drugs |
| 07/24/2003 | WO2003059272A2 Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors |
| 07/24/2003 | WO2003059270A2 Method for reducing morbidity and mortality in critically ill patients |
| 07/24/2003 | WO2003059268A2 A novel germ cell-specific contraceptive target |
| 07/24/2003 | WO2003059267A2 SELECTIVE 11β-HSD INHIBITORS AND METHODS FOR USE THEREOF |
| 07/24/2003 | WO2003059262A2 Method and composition for treating and preventing hiv infection and aids |
| 07/24/2003 | WO2003059257A2 Anti-angiogenic proteins and fragmentsand methods of use thereof |
| 07/24/2003 | WO2003059255A2 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 07/24/2003 | WO2003059253A2 Compositions and methods for altering glucose production |
| 07/24/2003 | WO2003059250A2 Compositions and methods for treating female sexual arousal disorder using hydrophobic-calcitonin gene related peptide |